Subject: ILC 2018 - Industry Satellite Symposia and Mini-Workshops 13 and 14 April
From: "EASL Office" <easloffice=[email-masked]>
To: David Sergeenko
Date: Fri, 6 Apr 2018 13:17:58 +0000
List-Id: 07d7246bcae2c9bb6eab3162bmc list <07d7246bcae2c9bb6eab3162b.1035413.list-id.mcsv.net>

Dear Colleague,

Thank you for registering to the annual EASL congress. We're looking forward to welcoming you to The International Liver Congress™ 2018 in Paris.

EASL thanks its Sponsors for their support and invites you to attend the industry satellite symposia and mini-workshops listed below:

Industry symposia

Friday 13 April

On Friday 13th of April, take the opportunity to create your perfect conference by voting for your favourite HCV topics and enjoy the fun and interactive agenda you designed. Listen to experts discussing the future of NASH diagnostics and drugs and how to overcome the different bottlenecks. Learn about the use of 3D liver disease models for accelerating drug discovery and how to develop innovative treatments for patients with rare liver disease through liver targeted RNAi therapeutics at the industry sponsored satellite symposia.

HCV Unsymposium: Your Meeting, Your Agenda!, AbbVie

18:30 - 20:00 | Main Plenary

Game changers in NASH management, Genfit

18:30 - 20:00 | South 1

Saturday 14 April

Gather with experts to discuss and debate the elimination and changing landscape of HCV treatment and the solutions for achieving HCV care. Learn about the challenges in the diagnostic and management of advanced fibrosis due to NASH. Participate in the debate on the role of lifestyle modifications and current therapy in the management of NASH advanced fibrosis on Saturday 14th April at the industry supported satellite symposia.

Shaping tomorrow together – addressing the challenges in the management of advanced fibrosis due to non-alcoholic steatohepatitis (NASH), Gilead Sciences Europe Ltd

12:30 - 14:00 | South 2

A Future Without Hepatitis C: What Will it Take?, MSD

12:30 - 14:00 | North 1

Mini-Workshops

Friday 13 April

Developing Innovative Treatments for Patients with Rare Diseases: Liver-Targeted RNA Interference Therapeutics, Alnylam Pharmaceuticals

18:30 - 19:30 | East 3

Defeating the animal: accelerate drug discovery with screen-able 3D Liver Disease Models, Insphero

18:30 - 19:30 | West 3

To view all other industry symposia, please visit the Congress website.

We look forward to meeting with you in Paris.

The EASL Team

[email-masked]

Copyright © 2018 EASL, The Home of Hepatology, All rights reserved.

You opted to receive information from EASL.

Our mailing address is:

EASL, The Home of Hepatology

7 rue Daubin
Geneva 1203
Switzerland

Add us to your address book

Want to change how you receive these emails?

You can update your preferences or unsubscribe from this list.